Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H1N1 Influenza”

247 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 247 results

Testing effectiveness (Phase 2)Study completedNCT00956202
What this trial is testing

Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 303
Not applicableStudy completedNCT01022931
What this trial is testing

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Who this might be right for
HealthyImmunosuppressedAsthmatic+1 more
University Hospital, Geneva 200
Testing effectiveness (Phase 2)Study completedNCT00938639
What this trial is testing

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults

Who this might be right for
Influenza Caused by the Novel Influenza A (H1N1) Virus
Seqirus 240
Not applicableStudy completedNCT01056185
What this trial is testing

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Who this might be right for
InfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
University of Minnesota 1,000
Testing effectiveness (Phase 2)Study completedNCT01089660
What this trial is testing

The Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 202
Testing effectiveness (Phase 2)WithdrawnNCT01037634
What this trial is testing

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT01072799
What this trial is testing

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Who this might be right for
Seasonal Influenza
Novavax 4,560
Testing effectiveness (Phase 2)Study completedNCT01052480
What this trial is testing

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza

Who this might be right for
Influenza AInfluenza B
National Institute of Allergy and Infectious Diseases (NIAID) 98
Testing effectiveness (Phase 2)Study completedNCT00976469
What this trial is testing

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 400
Testing effectiveness (Phase 2)Looking for participantsNCT07215858
What this trial is testing

BPL-1357 Against H1N1 Influenza Virus Challenge

Who this might be right for
InfluenzaHuman
National Institute of Allergy and Infectious Diseases (NIAID) 129
Not applicableEnded earlyNCT00970606
What this trial is testing

STIP: Statin Trial for Influenza Patients

Who this might be right for
Acute Respiratory Distress SyndromeInfluenzaH1N1 Influenza
Gordon Bernard 7
Post-approval studies (Phase 4)Study completedNCT01298102
What this trial is testing

Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients

Who this might be right for
Decreased Immunologic Activity [PE]InfluenzaRejection
Erasme University Hospital 185
Post-approval studies (Phase 4)UnknownNCT01151644
What this trial is testing

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo 5,000
Testing effectiveness (Phase 2)Ended earlyNCT01033955
What this trial is testing

Collaborative H1N1 Adjuvant Treatment Pilot Trial

Who this might be right for
Critically IllH1N1/Influenza Infection
Canadian Critical Care Trials Group 8
Large-scale testing (Phase 3)Study completedNCT01032395
What this trial is testing

Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus

Who this might be right for
H1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more
Chiltern Pesquisa Clinica Ltda 342
Post-approval studies (Phase 4)Study completedNCT01000831
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children

Who this might be right for
Influenza
University of British Columbia 167
Post-approval studies (Phase 4)Study completedNCT01114620
What this trial is testing

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

Who this might be right for
Influenza
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT00963157
What this trial is testing

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 789
Not applicableStudy completedNCT00985582
What this trial is testing

Antiviral Therapy for Influenza A H1N1

Who this might be right for
Influenza A Virus Infection
South East Asia Infectious Disease Clinical Research Network 181
Testing effectiveness (Phase 2)Study completedNCT02371668
What this trial is testing

Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model

Who this might be right for
H1N1 Influenza Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 104
Next Page